{
  "id": 5564550,
  "title": "Novartis and Bristol Myers are halting cell therapy trials for autoimmune diseases after patient deaths",
  "url": "https://urgent.news/2026/09/04/novartis-and-bristol-myers-are-halting-cell-therapy-trials-for",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-04T13:10:44.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/novartis-bristol-myers-car-t-autoimmune-trials-paused-090426"
  },
  "original_language": "en",
  "account": null,
  "summary": "Novartis paused 8 trials of its rap-cel therapy after patients died from a severe immune reaction; Bristol Myers followed as a precaution",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts",
        "url": "https://urgent.news/2026/09/02/autoimmune-car-t-faces-tough-questions-after-novartis-bristol-myers",
        "published": "2026-09-02T16:32:00.000Z"
      },
      {
        "outlet": "Endpoints News",
        "title": "Novartis CAR-T deaths raise questions over acceptable autoimmune risk",
        "url": "https://urgent.news/2026/09/02/novartis-car-t-deaths-raise-questions-over-acceptable-autoimmune-risk",
        "published": "2026-09-02T18:48:44.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}